Meningitis vaccine boosts immune response
Published: May 8, 2008 at 12:22 AM
HONOLULU, May 8 (UPI) -- Swiss-based Novartis says clinical trials show its new Menveo vaccine is effective in preventing four types of meningitis.
The drug, which has been developed for use from early infancy through adulthood, is in Phase III clinical trials, the company said in a news release.
The data was presented this week at the Pediatric Academic Societies' annual meeting in Honolulu.
A trial involving more than 2,100 11- to 18-year-olds showed Menveo helped trigger a strong immune response in a greater percentage of adolescents than the Sanofi-Aventis vaccine Menactra. Novartis said it plans to file for approval in the United States and Europe this year, The Wall Street Journal reported.
Meningitis kills 10 percent to 14 percent of the 1,400 to 2,800 U.S. patients diagnosed with the bacterial disease each year, the newspaper said.
The drug, which has been developed for use from early infancy through adulthood, is in Phase III clinical trials, the company said in a news release.
The data was presented this week at the Pediatric Academic Societies' annual meeting in Honolulu.
A trial involving more than 2,100 11- to 18-year-olds showed Menveo helped trigger a strong immune response in a greater percentage of adolescents than the Sanofi-Aventis vaccine Menactra. Novartis said it plans to file for approval in the United States and Europe this year, The Wall Street Journal reported.
Meningitis kills 10 percent to 14 percent of the 1,400 to 2,800 U.S. patients diagnosed with the bacterial disease each year, the newspaper said.
© 2008 United Press International. All Rights Reserved.
This material may not be reproduced, redistributed, or manipulated in any form.
This material may not be reproduced, redistributed, or manipulated in any form.
» Next in Science:
Telescopes search for signals from space
A crane lowers space shuttle Discovery toward the external tank and solid rocket boosters already stacked on the mobile launcher platform in high bay 3 of the Vehicle Assembly Building at Kennedy Space Center, Flordia. The stacking and mating took place in preparation for the launch on the STS-124 mission to the International Space Station, targeted to launch on May 31, 2008. (UPI Photo/Jim Grossmann/NASA)
Space Shuttle Discovery set to launch on May 31
Full Photo
| Slideshow
Latest Headlines
- Foo Fighters to play Harley gig
- Huckabee apologizes for Obama gun joke
- Canadian autoworkers reach labor deals
- Groups sue to stop Texas border fence
- Back injury sidelines Serena Williams
- GM reaches pact with union in Delta strike
- Calif. wine pioneer Mondavi dies
- Stroke outcome helped by clot-busting drug
Most Popular
- Huckabee apologizes for Obama gun joke
- Back injury sidelines Serena Williams
- Flights at N.Y.-area airports to be capped
- Study casts doubt on high-salt diet risk
- Calif. wine pioneer Mondavi dies
- GM reaches pact with union in Delta strike
- Stroke outcome helped by clot-busting drug
- Groups sue to stop Texas border fence